NB cell lines derived from high-stage, aggressive tumors as well as the rhabdomyosarcoma cell line RH-41 all presented with high cdk1/CCNB1 expression independent of the MYCN amplification status (Figure 2). The gene discussed is CCNB1; the disease is rhabdomyosarcoma.